Brenda Libby Coleman

Array ( [id] => 1063028 [patent_doc_number] => 06849641 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-01 [patent_title] => 'Azaindole tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 09/191199 [patent_app_country] => US [patent_app_date] => 1998-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31471 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849641.pdf [firstpage_image] =>[orig_patent_app_number] => 09191199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404055 [patent_doc_number] => RE037029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'N-[(3-heteroaryl-1-pyrrolidinyl)-alkyl]phthalimides and related compounds and their therapeutic utility' [patent_app_type] => 2 [patent_app_number] => 9/185968 [patent_app_country] => US [patent_app_date] => 1998-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86413 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 381 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/037/RE037029.pdf [firstpage_image] =>[orig_patent_app_number] => 185968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950113 [patent_doc_number] => 05955470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Derivatives of amide analogs of certain methano bridged quinolizines' [patent_app_type] => 1 [patent_app_number] => 9/181888 [patent_app_country] => US [patent_app_date] => 1998-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10341 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955470.pdf [firstpage_image] =>[orig_patent_app_number] => 181888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946050 [patent_doc_number] => 05977097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => '1-methylcarbapenem derivatives' [patent_app_type] => 1 [patent_app_number] => 9/176804 [patent_app_country] => US [patent_app_date] => 1998-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31934 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977097.pdf [firstpage_image] =>[orig_patent_app_number] => 176804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4201608 [patent_doc_number] => 06013814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Vitamin D analogues' [patent_app_type] => 1 [patent_app_number] => 9/175311 [patent_app_country] => US [patent_app_date] => 1998-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23785 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013814.pdf [firstpage_image] =>[orig_patent_app_number] => 175311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099127 [patent_doc_number] => 06096896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Process for the preparation of 4.5-diphenyloxazole-2-propanoic acid' [patent_app_type] => 1 [patent_app_number] => 9/172476 [patent_app_country] => US [patent_app_date] => 1998-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 815 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096896.pdf [firstpage_image] =>[orig_patent_app_number] => 172476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435987 [patent_doc_number] => 06355630 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Estra-1,3,5(10)-triene-7-thioethers' [patent_app_type] => B1 [patent_app_number] => 09/170355 [patent_app_country] => US [patent_app_date] => 1998-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9555 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355630.pdf [firstpage_image] =>[orig_patent_app_number] => 09170355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031830 [patent_doc_number] => 05994345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment' [patent_app_type] => 1 [patent_app_number] => 9/168419 [patent_app_country] => US [patent_app_date] => 1998-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15495 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994345.pdf [firstpage_image] =>[orig_patent_app_number] => 168419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979280 [patent_doc_number] => 05948738 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Stable liquid enzyme compositions and methods of use in contact lens cleaning and disinfecting systems' [patent_app_type] => 1 [patent_app_number] => 9/167031 [patent_app_country] => US [patent_app_date] => 1998-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9149 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948738.pdf [firstpage_image] =>[orig_patent_app_number] => 167031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157773 [patent_doc_number] => 06156747 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Isoxazolidine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/155839 [patent_app_country] => US [patent_app_date] => 1998-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6443 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 608 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156747.pdf [firstpage_image] =>[orig_patent_app_number] => 155839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356467 [patent_doc_number] => 06200984 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Naphtho-imidazo pyridine derivatives useful in treating central nervous system disorders' [patent_app_type] => 1 [patent_app_number] => 9/166021 [patent_app_country] => US [patent_app_date] => 1998-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8359 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 479 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200984.pdf [firstpage_image] =>[orig_patent_app_number] => 166021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360133 [patent_doc_number] => 06169084 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => '2-methyl-thieno-benzodiazepine formulation' [patent_app_type] => 1 [patent_app_number] => 9/163769 [patent_app_country] => US [patent_app_date] => 1998-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11885 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/169/06169084.pdf [firstpage_image] =>[orig_patent_app_number] => 163769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1040670 [patent_doc_number] => 06869968 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-22 [patent_title] => '2-(3H)-oxazolone derivatives and their use as COX-2 inhibitors' [patent_app_type] => utility [patent_app_number] => 09/158966 [patent_app_country] => US [patent_app_date] => 1998-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4613 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/869/06869968.pdf [firstpage_image] =>[orig_patent_app_number] => 09158966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304291 [patent_doc_number] => 06251893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity' [patent_app_type] => 1 [patent_app_number] => 9/156495 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19729 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 657 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251893.pdf [firstpage_image] =>[orig_patent_app_number] => 156495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1373533 [patent_doc_number] => 06562809 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => '3-bicycloindole compounds' [patent_app_type] => B1 [patent_app_number] => 09/156496 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16890 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562809.pdf [firstpage_image] =>[orig_patent_app_number] => 09156496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1578716 [patent_doc_number] => 06448253 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Adenosine A3 receptor modulators' [patent_app_type] => B1 [patent_app_number] => 09/154435 [patent_app_country] => US [patent_app_date] => 1998-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16067 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448253.pdf [firstpage_image] =>[orig_patent_app_number] => 09154435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4127091 [patent_doc_number] => 06127361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => '5,11-dihydrodibenzo[b,e][1,4]oxazepine derivatives and pharmaceutical compositions containing the same' [patent_app_type] => 1 [patent_app_number] => 9/147012 [patent_app_country] => US [patent_app_date] => 1998-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12006 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127361.pdf [firstpage_image] =>[orig_patent_app_number] => 147012 [rel_patent_id] =>[rel_patent_doc_number] =>)